Industry
Seelos Therapeutics Inc [SEEL] moved down -7.56: Why It’s Important
Seelos Therapeutics Inc [NASDAQ: SEEL] closed the trading session at $0.59. The company report on March 19, 2024 at 8:15 AM that Seelos Therapeutics Provides Update on Top-Line Results from its Amyotrophic Lateral Sclerosis (ALS) Study with SLS-005 (IV Trehalose). Seelos Therapeutics, Inc. (Nasdaq: SEEL)
